LUNG
Pulmonx CorporationNASDAQHealthcare$1.33+3.91%ClosedMarket Cap: $56.2M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.04
P/S
0.63
EV/EBITDA
-0.86
DCF Value
$-14.43
FCF Yield
-57.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
74.2%
Operating Margin
-59.3%
Net Margin
-59.7%
ROE
-82.8%
ROA
-41.8%
ROIC
-48.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $22.6M | 77.6% | $-9.9M | $-10.4M | $-0.25 | — |
| FY 2025 | $90.5M | 74.2% | $-53.7M | $-54.0M | $-1.33 | — |
| Q3 2025 | $21.5M | 74.7% | $-14.4M | $-14.0M | $-0.34 | — |
| Q2 2025 | $23.9M | 72.1% | $-14.8M | $-15.2M | $-0.38 | — |
| Q1 2025 | $22.5M | 72.5% | $-14.6M | $-14.4M | $-0.36 | — |
| Q4 2024 | $23.8M | 74.0% | $-13.4M | $-13.2M | $-0.33 | — |
| FY 2024 | $83.8M | 74.0% | $-57.7M | $-56.4M | $-1.44 | — |
| Q3 2024 | $20.4M | 73.7% | $-14.1M | $-14.1M | $-0.36 | — |
| Q2 2024 | $20.8M | 73.7% | $-15.6M | $-15.3M | $-0.39 | — |
| Q1 2024 | $18.9M | 74.1% | $-14.5M | $-13.7M | $-0.36 | — |
| Q4 2023 | $19.3M | 74.2% | $-13.9M | $-13.9M | $-0.36 | — |
| FY 2023 | $68.7M | 73.9% | $-61.9M | $-60.8M | $-1.60 | — |